SGLT2 Inhibitors: Alternatives or Complementary Therapeutic Options

doi 10.36502/2020/droa.6158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Asploro Open Access Publications

Related search

SGLT2 Inhibitors

2020English

SGLT2 Inhibitors: Mind the Gap

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Is Cancer Incidence Modified by SGLT2 Inhibitors?

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Class Effects of SGLT2 Inhibitors on Cardiorenal Outcomes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Sarcopenia, Frailty Circle, and Treatment With SGLT2 Inhibitors

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

SGLT2 Inhibitors for Primary Prevention of Cardiovascular Events

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

‘Architectural Alternatives or Alternatives to Architecture?’

2009English

Achalasia: Current Therapeutic Options

Therapeutic Advances in Chronic Disease
Medicine
2017English

Diabetes Research Open Access: Sodium Glucose Cotransporter2 (SGLT2) Inhibitors

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy